This is the HPRA’s latest weekly update on medicines shortages. We publish this information each week to keep patients and healthcare professionals informed of current and resolved shortages.
We recognise that medicine shortages can be challenging for those who rely on medicines for their health and well-being. It is the case that for many medicines supplied in Ireland, there is more than one strength, form, pack size or brand available from different suppliers.
Your doctor or pharmacist will often be able to supply an alternative strength, form or product to ensure continuity of treatment if the medicine you have been taking is unavailable.
Resolved shortages
The following shortages have been resolved and supply has resumed to the irish market:
| Product | Active Ingredient(s) |
| Azyter 15 mg/g Eye Drops, Solution PA1107/004/001 Laboratoires Thea | Azithromycin |
| Dioralyte Rebalance Natural Powder for Oral Solution PA23180/023/003 Phoenix Labs | Sodium chloride, potassium chloride, glucose & disodium hydrogen citrate |
| Ezetimibe 10mg Tablets PA0577/198/001 McDermott Laboratories Ltd., T/A Gerard Laboratories | Ezetimibe |
| Fungizone 50mg Powder for Sterile Concentrate PA2239/004/001 CHEPLAPHARM Arzneimittel GmbH | Amphotericin |
| Hycamtin 0.25mg Capsules EU/1/96/027/006 Sandoz Pharmaceuticals d.d | Topotecan |
| MacroBID 100mg Prolonged Release Capsules PA1142/033/001 Amdipharm Limited | Nitrofurantoin |
| Meptid 200 mg film-coated Tablets PA0968/005/002 Almirall, S.A. | Meptazinol |
| Praluent Solution for Injection in Pre-Filled Pen EU/1/15/1031/008 Sanofi-Aventis Groupe | Alirocumab |
| Rasagiline Clonmel 1mg tablets PA0126/276/001 Clonmel Healthcare Ltd | Rasagiline |
| Roaccutane 10 mg soft capsules PA2307/007/001 Roche Products (Ireland) Ltd | Isotretinoin |
| Rosuvastatin Krka 20mg Film Coated Tablets PA1347/016/003 KRKA, d.d., Novo mesto | Rosuvastatin |
| Rosuvastatin Teva Pharma 40mg Film Coated Tablets PA1986/024/004 Teva Pharma B.V | Rosuvastatin |
| SANDOSTATIN 500 microgram/1 ml, solution for injection/infusion PA0896/028/003 Novartis Ireland Limited | Octreotide |
| Teveten 600mg Film Coated Tablets PA2010/017/002 Mylan IRE Healthcare Limited | Eprosartan |
Newly notified shortages
The HPRA has been notified of a shortage of the following products:
| Product | Active Ingredient(s) |
| Abstral 200 microgram sublingual tablets PA2288/004/003 Kyowa Kirin Holdings B.V. | Fentanyl |
| Asacolon 800 mg Gastro-resistant Tablets PA2018/001/002 Tillotts Pharma GmbH | Mesalazine |
| Clarithromycin Teva 250 mg film-coated tablets PA0749/148/001 Teva Pharma B.V. | Clarithromycin |
| Clarithromycin Teva 500 mg film-coated tablets PA0749/148/002 Teva Pharma B.V. | Clarithromycin |
| Dutasteride/Tamsulosin hydrochloride Pinewood 0.5 mg/0.4 mg hard capsules PA0281/216/001 Pinewood Laboratories Ltd | Tamsulosin & dutasteride |
| Gelaspan Solution for Infusion PA0736/034/001 B. Braun Melsungen AG | Various |
| Irinotecan Hydrochloride 20 mg/mL concentrate for solution for infusion (500mg presentation) PA1986/068/001 Teva B.V. | Irinotecan |
| Levothyroxine Teva 100 micrograms Tablets PA0749/143/003 Teva Pharma B.V. | Levothyroxine |
| Marixino 10 milligram(s) Film-coated tablet EU/1/13/820/002 KRKA, d.d., Novo mesto | Memantine |
| Marixino 10 milligram(s) Film-coated tablet EU/1/13/820/006 KRKA, d.d., Novo mesto | Memantine |
| Questran 4g/sachet powder for oral suspension PA2239/005/001 CHEPLAPHARM Arzneimittel GmbH | Colestyramine resin |
| Rasilez 300mg Film-coated tablet EU/1/07/405/032 Noden Pharma DAC | Aliskiren |
| Tenofovir disoproxil Mylan 245mg Film Coated Tablets EU/1/16/1129/005 Mylan Pharmaceuticals Limited | Tenofovir disoproxil |
| TEVETEN 400 mg, film-coated tablets PA2010/017/001 Mylan IRE Healthcare Limited | Eprosartan |
| Vancomycin 500mg Powder for Concentrate for Solution for Infusion and Oral Solution PA1122/008/001 Noridem Enterprises Limited | Vancomycin |
Please see the shortages section of the HPRA website for further information
The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.